Medarex, PrimaBioMed Ltd. deal

MEDX and PRR subsidiary Oncomab Ltd. (Melbourne, Australia) will develop an antibody against Oncomab's undisclosed tumor antigen expressed on the surface of solid tumors including breast, lung, colon...